Stay updated on Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for nivolumab, ipilimumab, and stereotactic radiation in salivary gland cancer is now available, including its eligibility criteria, treatment plan, outcome measures, and posted results and study documents.
    Difference
    60%
    Check dated 2026-11-07T14:00:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:54:14.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-24T18:02:44.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T17:59:15.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T19:00:03.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden screen instead of the usual content, indicating access restrictions. This change replaces the prior study details with a standard error page and minimal navigation.
    Difference
    20%
    Check dated 2026-09-19T18:22:37.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab SBRT in Salivary Gland Cancers Clinical Trial page.